Day: December 7, 2021

ImprimisRx to assume full responsibility for U.S. sales and marketing activities for DEXYCU® and absorb the majority of EyePoint’s DEXYCU commercial organization; EyePoint to retain DEXYCU NDA, revenue recognition, manufacturing and distribution responsibilities for all markets WATERTOWN, Mass. and NASHVILLE, Tenn. and CARLSBAD, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, and ImprimisRx, one of the nation’s leading ophthalmic-focused pharmaceutical businesses and a wholly-owned subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today jointly announced the expansion of their commercial alliance in which ImprimisRx will assume responsibility...

NEWARK, NJ, Dec. 07, 2021 (GLOBE NEWSWIRE) — IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, today reported results for the first quarter of its 2022 fiscal year, the three months ended October 31, 2021. FIRST QUARTER FISCAL YEAR 2022 (1Q22) HIGHLIGHTS (Throughout this release, results are for 1Q22 and are compared to 1Q21 unless otherwise noted. Loss per share, EPS, Non-GAAP loss per share*, and Non-GAAP EPS* are per diluted share.)Consolidated revenue increased 8% to $370 million from $343 million. Key business unit revenue included:National Retail Solutions (NRS) revenue increased 104.3% to $10.1 million. net2phone subscription revenue increased 37.5% to $12.5 million. Money Transfer revenue decreased 18% to $12.5 million. The decrease was entirely...

CALGARY, Alberta, Dec. 07, 2021 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”, the “Company”, “we” or “us”) (Nasdaq: DRTT, TSX: DRT), an interior construction company that uses proprietary software to design, manufacture and install fully customizable environments, announced today that its board of directors (the “Board”), in response to a requisition made by activist investor 22NW Fund, LP (the “Activist”), has called an annual and special meeting of shareholders (the “Meeting”) to be held on April 26, 2022 (the “Meeting Date”). The Meeting will deal both with normal course matters and matters related to the requisition. Following receipt of the Activist’s requisition, a special committee of the Board comprised exclusively of independent directors (the “Special Committee”) reviewed and considered the requisition...

NASHVILLE, Tenn., Dec. 07, 2021 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the resignation of Chief Financial Officer Kyle Wailes to pursue a CEO opportunity at a healthcare company. Wailes will remain in his role to support the transition of responsibilities through March 1, 2022 and will continue to own a significant amount of equity in the Company. David Katzman, Chief Executive Officer of SmileDirectClub, said, “On behalf of our entire team, I would like to thank Kyle for his leadership and the commitment he has demonstrated to SmileDirectClub throughout a critical stage in our growth from startup to public company, including through the challenges of the pandemic and the recent inflationary macro environment....

MONTREAL, Dec. 07, 2021 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce that it has completed a closing of a non-brokered private placement by issuing a total of 2,228,875 flow-through common shares (the “Flow-Through Shares”) at $0.80 per share and 760,870 Flow-Through Shares at $0.92, for total gross proceeds of $2,483,100. The securities issued in the private placement are subject to a four-month hold period expiring on April 8, 2022. Midland will use the private placement proceeds to fund exploration works on its properties located in Quebec. The Insiders’ participation for $189,000 is exempt from the formal valuation and minority shareholder approval requirements provided under Regulation 61-101 respecting Protection of Minority Security Holders in Special Transactions (“Regulation...

MENLO PARK, Calif. and BOSTON, Dec. 07, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer and other diseases, today announced that it has commenced an underwritten public offering of its common stock. Adicet also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares sold at the public offering price, less underwriting discounts and commissions. All of the shares in the proposed offering are to be sold by Adicet. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies LLC and Guggenheim Securities, LLC...

CHICAGO, Dec. 07, 2021 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its first quarter of fiscal year 2022.                                                                                                                        First Quarter                                                                                                                      (in thousands, except per share amounts) Ended October 31                                                                                                                        2021 2020 Change                                                                                                                      Consolidated...

Preliminary FY22 Q2 revenue expected to increase over 27% year-over-year to $54.0 million; backlog increases to $146.9 million LAFOX, Ill., Dec. 07, 2021 (GLOBE NEWSWIRE) — Richardson Electronics, Ltd. (NASDAQ: RELL) today announced preliminary results for its second quarter ended November 27, 2021, in conjunction with the Company’s presentation at the Sidoti & Company Winter Virtual Micro Cap Investor Conference. The presentation is available at https://sidoti.zoom.us/webinar/register/WN_Bl7VpxicSvmvOgzuDJBaBQ or on the Company’s investor relations website at https://www.rell.com/investor-relations. Preliminary Fiscal Year 2022 second quarter net sales are expected to be approximately $54.0 million, representing 27.3% growth compared to the prior year’s second quarter. Revenue increased across the Company’s three business...